Robert
1 posts
Posts By Robert
Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (Stage IIIB/C/D-IV M1a) Melanoma With Injectable Disease – NCT04330430
Study Overview Details NCTid: NCT04330430 Status: Not yet recruiting Condition or Disease: Melanoma Design Style: Interventional Sponsor: The Netherlands Cancer Institute Study Description…
Share